论文部分内容阅读
目的观察西沙必利混悬液及思密达联合应用对母乳性黄疸的临床疗效。方法选择早发型母乳性黄疸患儿 (总胆红素 <2 5 6 .5μmol/L ) ,分别给予西沙必利混悬液及思密达喂服。结果服药后黄疸即未再加重 ,服药 3天后皮肤黄疸减轻 ,胆红素平均降低37.5μmol/L ,服药 7天后部分患儿黄疸消褪 ,胆红素值均降至安全范围内 ,有效率 10 0 %。结论西沙必利混悬液及思密达联合应用治疗母乳性黄疸是一种安全、方便、利于推广 ,有利于母、婴身心健康 ,并不影响母乳喂养的有效手段
Objective To observe the clinical efficacy of cisapride suspension combined with Smecta for breast milk jaundice. Methods The children with early-onset breast milk jaundice (total bilirubin <2.56 μmol / L) were given cisapride suspension and sidaimidine respectively. Results jaundice was not aggravated after taking medicine for 3 days, the skin jaundice was reduced, the average bilirubin was reduced 37.5μmol / L, after taking 7 days, some children faded jaundice, bilirubin values were reduced to a safe range, the effective rate of 10 0%. Conclusion The combination of cisapride and Smecta in the treatment of breast milk jaundice is an effective, safe, convenient and beneficial method to promote mother’s and infants’s physical and mental health without affecting breastfeeding